A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity.
about
Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's diseaseStatic magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385Pathophysiological roles for purines: adenosine, caffeine and urate.New synaptic and molecular targets for neuroprotection in Parkinson's disease.Selective blockade of A(2A) receptor protects against neurotoxicity induced by kainic acid in young rats.Paraquat- and rotenone-induced models of Parkinson's disease.
P2860
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A2A adenosine receptor antagon ...... otenone-induced neurotoxicity.
@en
A2A adenosine receptor antagon ...... otenone-induced neurotoxicity.
@nl
type
label
A2A adenosine receptor antagon ...... otenone-induced neurotoxicity.
@en
A2A adenosine receptor antagon ...... otenone-induced neurotoxicity.
@nl
prefLabel
A2A adenosine receptor antagon ...... otenone-induced neurotoxicity.
@en
A2A adenosine receptor antagon ...... otenone-induced neurotoxicity.
@nl
P2093
P1476
A2A adenosine receptor antagon ...... rotenone-induced neurotoxicity
@en
P2093
Alessia Autuori
Cinzia Costa
Elisa Luchetti
Franco Borsini
Massimiliano Di Filippo
Michela Tantucci
Paolo Calabresi
Sabrina Siliquini
Vincenzo Belcastro
P304
P356
10.1016/J.EXPNEUROL.2009.01.010
P407
P577
2009-01-29T00:00:00Z